Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5759_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
93 Мб
Скачать
Chapter 39 The Fetal Urogenital Tract 1387
the cloaca, and urorectal septum malformation sequence. Am J Med Genet A 2007;143A:1025-1031.
161. Gonzalez R, De Filippo R, Jednak R, Barthold JS. Urethral atresia: long-term outcome in 6 children who survived the neonatal period. J Urol 2001;165:2241-2244.
162. Jaramillo D, Lebowitz RL, Hendren WH. The cloacal malformation: radiologic findings and imaging recommendations. Radiology 1990;177:441-448.
163. Johnson MP, Corsi P, Bradfield W, et al. Sequential urinalysis improves evaluation of fetal renal function in obstructive uropathy. Am J Obstet Gynecol 1995;173:59-65.
164. Nicolini U, Fisk NM, Rodeck CH, Beacham J. Fetal urine biochem­istry: an index of renal maturation and dysfunction. Br J Obstet Gynaecol 1992;99:46-50.
165. Lipitz S, Ryan G, Samuell C, et al. Fetal urine analysis for the assess­ment of renal function in obstructive uropathy. Am J Obstet Gynecol 1993;168:174-179.
166. Muller F, Dommergues M, Mandelbrot L, et al. Fetal urinary bio­chemistry predicts postnatal renal function in children with bilateral obstructive uropathies. Obstet Gynecol 1993;82:813-820.
167. Crombleholme TM, Harrison MR, Golbus MS, et al. Fetal interven­tion in obstructive uropathy: prognostic indicators and efficacy of intervention. Am J Obstet Gynecol 1990;162:1239-1244.
168. Qureshi F, Jacques SM, Seifman B, et al. In utero fetal urine analysis and renal histology correlate with the outcome in fetal obstructive uropathies. Fetal Diagn Ther 1996;11:306-312.
169. Muller F, Dommergues M, Bussieres L, et al. Development of human renal function: reference intervals for 10 biochemical markers in fetal urine. Clin Chem 1996;42:1855-1860.
170. Nicolaides KH, Cheng HH, Snijders RJ, Moniz CF. Fetal urine biochemistry in the assessment of obstructive uropathy. Am J Obstet Gynecol 1992;166:932-937.
171. Berry SM, Lecolier B, Smith RS, et al. Predictive value of fetal serum beta 2-microglobulin for neonatal renal function. Lancet 1995; 345:1277-1278.
172. Nicolini U, Spelzini F. Invasive assessment of fetal renal abnormali­ties: urinalysis, fetal blood sampling and biopsy. Prenat Diagn 2001;21:964-969.
173. Morris RK, Quinlan-Jones E, Kilby MD, Khan KS. Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in cases of congenital urinary tract obstruction. Prenat Diagn 2007;27:900-911.
174. Holmes N, Harrison MR, Baskin LS. Fetal surgery for posterior urethral valves: long-term postnatal outcomes. Pediatrics 2001; 108:E7.
175. Makino Y, Kobayashi H, Kyono K, et al. Clinical results of fetal obstructive uropathy treated by vesicoamniotic shunting. Urology 2000;55:118-122.
176. McLorie G, Farhat W, Khoury A, et al. Outcome analysis of vesi­coamniotic shunting in a comprehensive population. J Urol 2001;166:1036-1040.
177. Freedman AL, Johnson MP, Smith CA, et al. Long-term outcome in children after antenatal intervention for obstructive uropathies. Lancet 1999;354:374-377.
178. Clark TJ, Martin WL, Divakaran TG, et al. Prenatal bladder drain­age in the management of fetal lower urinary tract obstruction: a systematic review and meta-analysis. Obstet Gynecol 2003;102: 367-382.
179. Biard JM, Johnson MP, Carr MC, et al. Long-term outcomes in children treated by prenatal vesicoamniotic shunting for lower urinary tract obstruction. Obstet Gynecol 2005;106:503-508.
180. Gearhart JP, Ben-Chaim J, Jeffs RD, Sanders RC. Criteria for the prenatal diagnosis of classic bladder exstrophy. Obstet Gynecol 1995;85:961-964.
181. Ben-Neriah Z, Withers S, Thomas M, et al. OEIS complex: prenatal ultrasound and autopsy findings. Ultrasound Obstet Gynecol 2007;29:170-177.
182. Tiblad E, Wilson RD, Carr M, et al. OEIS sequence: a rare con­genital anomaly with prenatal evaluation and postnatal outcome in six cases. Prenat Diagn 2008;28:141-147.
The Genital Tract
183. Reece EA, Winn HN, Wan M, et al. Can ultrasonography replace amniocentesis in fetal gender determination during the early second trimester? Am J Obstet Gynecol 1987;156:579-581.
184. Harrington K, Armstrong V, Freeman J, et al. Fetal sexing by ultrasound in the second trimester: maternal preference and profes­sional ability [see comment]. Ultrasound Obstet Gynecol 1996;8: 318-321.
185. Meagher S, Davison G. Early second-trimester determination of fetal gender by ultrasound [see comment]. Ultrasound Obstet Gynecol 1996;8:322-324.
186. Lev-Toaff AS, Ozhan S, Pretorius D, et al. Three-dimensional multiplanar ultrasound for fetal gender assignment: value of the mid-sagittal plane. Ultrasound Obstet Gynecol 2000;16:345-350.
187. Whitlow BJ, Lazanakis MS, Economides DL. The sonographic identification of fetal gender from 11 to 14 weeks of gestation [see comment]. Ultrasound Obstet Gynecol 1999;13:301-304.
188. Efrat Z, Akinfenwa OO, Nicolaides KH. First-trimester determina­tion of fetal gender by ultrasound [see comment]. Ultrasound Obstet Gynecol 1999;13:305-307.
189. Mazza V, Falcinelli C, Paganelli S, et al. Sonographic early fetal gender assignment: a longitudinal study in pregnancies after in vitro fertilization. Ultrasound Obstet Gynecol 2001;17:513-516.
190. Achiron R, Pinhas-Hamiel O, Zalel Y, et al. Development of fetal male gender: prenatal sonographic measurement of the scrotum and evaluation of testicular descent [see comment]. Ultrasound Obstet Gynecol 1998;11:242-245.
191. Pretorius DH, Halsted MJ, Abels W, et al. Hydroceles identified prenatally: common physiologic phenomenon? J Ultrasound Med 1998;17:49-52.
192. Meizner I, Levy A, Katz M, et al. Prenatal ultrasonographic diagnosis of fetal scrotal inguinal hernia. Am J Obstet Gynecol 1992; 166:907-909.
193. Mandell J, Bromley B, Peters CA, Benacerraf BR. Prenatal sono­graphic detection of genital malformations. J Urol 1995;153: 1994-1996.
194. Shapiro E. The sonographic appearance of normal and abnormal fetal genitalia. J Urol 1999;162:530-533.
195. Cheikhelard A, Luton D, Philippe-Chomette P, et al. How accurate is the prenatal diagnosis of abnormal genitalia? J Urol 2000;164: 984-987.
196. Meizner I. The “tulip sign”: a sonographic clue for in-utero diagnosis of severe hypospadias. Ultrasound Obstet Gynecol 2002;19:317.
197. McGaughran JM, Clayton PT, Mills KA, et al. Prenatal diagnosis of Smith-Lemli-Opitz syndrome. Am J Med Genet 1995;56: 269-271.
198. Shapiro E, Santiago JV, Crane JP. Prenatal fetal adrenal suppression following in utero diagnosis of congenital adrenal hyperplasia. J Urol 1989;142:663-666; discussion 667-668.
199. Saada J, Grebille AG, Aubry MC, et al. Sonography in prenatal diagnosis of congenital adrenal hyperplasia. Prenat Diagn 2004; 24:627-630.
200. Carlson AD, Obeid JS, Kanellopoulou N, et al. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol 1999;69:19-29.
201. New MI. An update of congenital adrenal hyperplasia. Ann NY Acad Sci 2004;1038:14-43.
202. Pajkrt E, Petersen OB, Chitty LS. Fetal genital anomalies: an aid to diagnosis. Prenat Diagn 2008;28:389-398.
203. Mazza V, Di Monte I, Ceccarelli PL, et al. Prenatal diagnosis of female pseudohermaphroditism associated with bilateral luteoma of pregnancy: case report. Hum Reprod 2002;17:821-824.
204. Picone O, Laperelle J, Sonigo P, et al. Fetal magnetic resonance imaging in the antenatal diagnosis and management of hydrocolpos. Ultrasound Obstet Gynecol 2007;30:105-109.
205. Hayashi S, Sago H, Kashima K, et al. Prenatal diagnosis of fetal hydrometrocolpos secondary to a cloacal anomaly by magnetic resonance imaging. Ultrasound Obstet Gynecol 2005;26:577-
579.
206. Dhombres F, Jouannic JM, Brodaty G, et al. Contribution of pre­natal imaging to the anatomical assessment of fetal hydrocolpos. Ultrasound Obstet Gynecol 2007;30:101-104.
207. Garel L, Filiatrault D, Brandt M, et al. Antenatal diagnosis of ovarian cysts: natural history and therapeutic implications. Pediatr Radiol 1991;21:182-184.
208. Nussbaum AR, Sanders RC, Hartman DS, et al. Neonatal ovarian cysts: sonographic-pathologic correlation. Radiology 1988;168: 817-821.
1388 PART IV Obstetric Sonography
209. Heling KS, Chaoui R, Kirchmair F, et al. Fetal ovarian cysts: prenatal diagnosis, management and postnatal outcome. Ultrasound Obstet Gynecol 2002;20:47-50.
210. Meizner I, Levy A, Katz M, et al. Fetal ovarian cysts: prenatal ultra­sonographic detection and postnatal evaluation and treatment. Am J Obstetr Gynecol 1991;164:874-878.
211. Giorlandino C. Antenatal ultrasonographic diagnosis and manage­ment of fetal ovarian cysts. Int J Gynecol Obstet 1994;44:27-31.
212. Bagolan P, Giorlandino C, Nahom A, et al. The management of fetal ovarian cysts. J Pediatr Surg 2002;37:25-30.
213. Bryant AE, Laufer MR. Fetal ovarian cysts: incidence, diagnosis and management. J Reprod Med 2004;49:329-337.
214. Monnery-Noche ME, Auber F, Jouannic JM, et al. Fetal and neonatal ovarian cysts: is surgery indicated? Prenat Diagn 2008; 28:15-20.
CHAPTER 40
The Fetal
Musculoskeletal System
Phyllis Glanc, David Chitayat, and Sheila Unger
Chapter Outline
NORMAL FETAL SKELETON
Development Extremity Measurements
SONOGRAPHIC EVALUATION OF
FETUS WITH SKELETAL DYSPLASIA
Positive Family History Abnormal Bone Length or
Appearance Three-Dimensional Ultrasound Additional Imaging
LETHAL SKELETAL DYSPLASIAS
Thanatophoric Dysplasia Achondrogenesis Osteogenesis Imperfecta
Hypophosphatasia Campomelic Dysplasia Short-Rib Polydactyly Syndromes Other Dysplasias
NONLETHAL OR VARIABLE-
PROGNOSIS SKELETAL DYSPLASIAS
Heterozygous Achondroplasia Diastrophic Dysplasia Asphyxiating Thoracic Dysplasia Ellis–van Creveld Syndrome Chondrodysplasia Punctata Dyssegmental Dysplasia Osteogenesis Imperfecta Types I, III,
IV—Nonlethal Types
Congenital bone disorders are a heterogeneous group
of disorders primarily affecting the growth and develop­ment of the musculoskeletal system. There are three major categories. The skeletal dysplasias are developmen­tal disorders of chondro-osseous tissue caused by single­gene disorders with prenatal and postnatal manifestations. the dysostoses are single-gene disorders resulting in mal­formations of individual bones caused by transient abnormalities of signaling factors. Disruptions are mor­phologic defects of an organ or larger region resulting from extrinsic breakdown or interference with an origi­nally normal developmental process. skeletal dysplasias, also called osteochondrodysplasias, diagnosed prenatally or during the neonatal period, excluding limb amputations, is 2.4 to 4.5 per 10,000 births. More than 400 subtypes have been reported (Table 40-1).
The number of recognized genetic disorders with a substantial skeletal component is increasing, and the dis­tinction among dysplasias, metabolic bone disorders, dysostoses, and malformation syndromes is constantly evolving. Despite increased knowledge about the genetic etiology of many of these conditions and the improved ability to diagnose and categorize these disorders cor­rectly, the clinical and imaging features remain a funda­mental tool for diagnosing and directing the molecular
1
The prevalence of
2-5
LIMB REDUCTION DEFECTS AND
ASSOCIATED CONDITIONS
Proximal Focal Femoral Deficiency Caudal Regression Syndrome and
Sirenomelia Amniotic Band Sequence Limb Reduction Defects Radial Ray Defects Arthrogryposis Multiplex Congenita
HAND AND FOOT DEFORMITIES SKELETAL FINDINGS
ASSOCIATED WITH
ANEUPLOIDY
2,6
investigation.
Although many fetal skeletal dysplasias can be accurately identified by prenatal ultrasound, this remains a challenging task because of the low incidence, phenotypic variability and wide range of appearances. The majority of cases have no family history of a similar condition. Nonetheless, the majority of lethal skeletal
dysplasias, including thanatophoric dysplasia, achon­drogenesis, and osteogenesis imperfecta type II, can be
diagnosed solely on the basis of prenatal ultrasound. Tretter et al.9 determined that 26 of 27 lethal skeletal dysplasias were identified correctly by prenatal ultra­sound; however, only 13 of 27 (48%) received an accu­rate specific antenatal diagnosis.
9
Eight of 14 (57%) underwent a substantial change in genetic counseling when cytogenetic, molecular (including microarray), pathologic, and radiologic findings were added. Thus, although the ultrasound diagnosis of a lethal skeletal dysplasia is highly accurate (85%-95%), a correct spe­cific diagnosis is obtained in only 40% to 55% of
7-9
cases.
Nonetheless, the highly accurate prenatal determina­tion of the lethality of a given skeletal dysplasia is crucial in helping couples with decision making. Typically, a combination of ultrasound, radiologic, genetic, patho­logic, and cytogenetic investigation is required to classify a specific congenital musculoskeletal disorder. A prenatal
7
8
1389
1390 PART IV Obstetric Sonography
TABLE 40-1. BIRTH PREVALENCE OF
SKELETAL DYSPLASIAS
SKELETAL DYSPLASIA
Lethal Dysplasias
Thanatophoric dysplasia 2.4 to 6.9 Achondrogenesis 0.9 to 2.3 Osteogenesis imperfecta type IIA 1.8 Hypophosphatasia congenita 1.0
Variable-Prognosis Dysplasias
Rhizomelic chondrodysplasia punctata 0.5 to 0.9 Campomelic dysplasia 1.0 to 1.5 Asphyxiating thoracic dystrophy 0.8 to 1.4 Ellis–van Creveld syndrome 0.7 Osteogenesis imperfecta (other types) 1.8
Nonlethal Dysplasias
Heterozygous achondroplasia 3.3 to 3.8
Overall 24.4 to 75.0
PREVALENCE PER
100,000 BIRTHS
diagnosis of a musculoskeletal anomaly will provide an opportunity for genetic counseling, pregnancy termina­tion, or tertiary-level care when appropriate. A multidis­ciplinary approach involving the medical imaging team, obstetrician, medical geneticist, and perinatologist is important in optimizing the accuracy of prognosis and recurrence risk. This information is crucial to the family and to medical personnel involved in planning clinical management for both current and future pregnancies. This chapter uses a “key features’’ approach to the sono­graphic diagnosis of the common skeletal dysplasias to aid in the classification and differential diagnosis.
Of the secondary ossification centers in the long bones, only the distal femoral epiphysis, the proximal tibial epiphysis, and occasionally the proximal humeral epiphysis ossify prenatally (Fig. 40-1). The unossified epiphysis appears hypoechoic, with a variably, mildly echogenic center. Ossification begins centrally. The distal femoral epiphysis can ossify as early as 29 weeks’ menstrual age and as late as 34 weeks. When it measures greater than 7 mm, the menstrual age is generally later than 37 weeks. to ossify by 35 menstrual weeks.
14,15
The proximal tibial epiphysis begins
15
In uncomplicated pregnancies the combination of a distal femoral epiphy­sis of 3 mm or greater and the presence of a proximal tibial epiphysis is considered a reliable marker of pul­monary maturity.16 Intrauterine growth restriction (IUGR) may delay ossification of the distal femoral epiphysis and proximal tibial epiphysis. The earliest sec­ondary epiphysis to ossify is the calcaneus, at approxi­mately 20 weeks’ gestation, thus marking the earliest point that assessment of delayed ossification of the sec­ondary epiphyseal centers can be attempted.
The fascia within the muscle is highly echogenic compared with the relatively hypoechoic cartilage. The fetal musculature is slightly more echogenic than the relatively hypoechoic cartilage. The fetal joint spaces, in particular the knee, appear echogenic because of the combination of synovium, fat, and microvasculature.
11
The normal development and ultimate function of the fetal musculoskeletal system depend on fetal move- ments, which start by the second half of the first trimes­ter. In the absence of normal fetal motion, the bones and muscles will be underdeveloped, the chest will be narrow, and joint contractures and postural deformities may also occur.
NORMAL FETAL SKELETON
Development
The high level of intrinsic contrast of the fetal extremities places them among the earliest structures that can be evaluated by ultrasound. By the end of the embryonic period, the differentiation of bones, joints, and muscu­lature is similar to that of an adult and is associated with increased fetal movements. can demonstrate the limb buds by 7 weeks’ gestation, and the foot and hand plates are visible by 8 weeks. Osteogenesis begins in the clavicle and mandible by 8 weeks as well. By 11 to 12 weeks, the primary ossifica- tion centers of the long bones (e.g., scapula, ileum), as well as the limb articulations and phalanges, can be identified. The ischium, metacarpals, and metatarsals ossify during the fourth month of gestation. The pubis, calcaneus, and talus ossify during the fifth and sixth months. Ossification of the other tarsal and carpal bones occurs postnatally.
13
The direction of growth in the long bones is from proximal to distal, and the lower extremi­ties lag slightly behind the upper extremities.
10,11
Transvaginal ultrasound
11
12
Extremity Measurements
It is a standard practice to assess femur length (FL) as part of the evaluation of fetal size and morphology. Although measurement of all the long bones is not required in a routine obstetric ultrasound, an overall evaluation of the fetal skeleton should be performed to ensure the presence and bilateral symmetry of the tubular bones. Available charts provide guidance for correlating the length of the extremities with the gestational age (Table 40-2).
The longest femur measurement, excluding both proximal and distal epiphyses, is usually chosen. The inclusion of the distal femur point, or the specular reflection of the lateral aspect of the distal femoral epiphysis cartilage, is the most common reason for overestimating FL
17
(Fig. 40-2, A). An oblique FL
measurement will result in undermeasurement. The lateral border of the femur in the near field of the trans­ducer appears straight, whereas the medial border of the femur in the far field has a curved appearance (Fig. 40-2, B).
18
A B
FIGURE 40-1. Secondary ossification centers in fetus at 38 weeks’ gestational age. A, View of the femur and
distal femoral ossification center (arrow). B, View of distal femur and proximal tibia with distal femoral ossification center (arrow) and proximal tibial ossification center (arrowhead).
TABLE 40-2. NORMAL EXTREMITY LONG-BONE LENGTHS AND BIPARIETAL DIAMETERS
AT DIFFERENT MENSTRUAL AGES*
MENSTRUAL AGE
13 2.3 (0.3) 1.1 (0.2) 0.9 (0.2) 0.8 (0.2) 1.0 (0.2) 0.6 (0.2) 0.8 (0.3) 14 2.7 (0.3) 1.3 (0.2) 1.0 (0.2) 0.9 (0.3) 1.2 (0.2) 0.8 (0.2) 1.0 (0.2) 15 3.0 (0.1) 1.5 (0.2) 1.3 (0.2) 1.2 (0.2) 1.4 (0.2) 1.1 (0.1) 1.2 (0.1) 16 3.3 (0.2) 1.9 (0.3) 1.6 (0.3) 1.5 (0.3) 1.7 (0.2) 1.4 (0.3) 1.6 (0.3) 17 3.7 (0.3) 2.2 (0.3) 1.8 (0.3) 1.7 (0.2) 2.0 (0.4) 1.5 (0.3) 1.7 (0.3) 18 4.2 (0.5) 2.5 (0.3) 2.2 (0.3) 2.1 (0.3) 2.3 (0.3) 1.9 (0.2) 2.2 (0.3) 19 4.4 (0.4) 2.8 (0.3) 2.5 (0.3) 2.3 (0.3) 2.6 (0.3) 2.1 (0.3) 2.4 (0.3) 20 4.7 (0.4) 3.1 (0.3) 2.7 (0.2) 2.6 (0.2) 2.9 (0.3) 2.4 (0.2) 2.7 (0.4) 21 5.0 (0.5) 3.5 (0.4) 3.0 (0.4) 2.9 (0.4) 3.2 (0.4) 2.7 (0.4) 3.0 (0.4) 22 5.5 (0.5) 3.6 (0.3) 3.2 (0.3) 3.1 (0.3) 3.3 (0.3) 2.8 (0.5) 3.1 (0.4) 23 5.8 (0.5) 4.0 (0.4) 3.6 (0.2) 3.4 (0.2) 3.7 (0.3) 3.1 (0.4) 3.5 (0.2) 24 6.1 (0.5) 4.2 (0.3) 3.7 (0.3) 3.6 (0.3) 3.8 (0.4) 3.3 (0.4) 3.6 (0.4) 25 6.4 (0.5) 4.6 (0.3) 4.0 (0.3) 3.9 (0.4) 4.2 (0.4) 3.5 (0.3) 3.9 (0.4) 26 6.8 (0.5) 4.8 (0.4) 4.2 (0.3) 4.0 (0.3) 4.3 (0.3) 3.6 (0.4) 4.0 (0.3) 27 7.0 (0.3) 4.9 (0.3) 4.4 (0.3) 4.2 (0.3) 4.5 (0.2) 3.7 (0.3) 4.1 (0.2) 28 7.3 (0.5) 5.3 (0.5) 4.5 (0.4) 4.4 (0.3) 4.7 (0.4) 3.9 (0.4) 4.4 (0.5) 29 7.6 (0.5) 5.3 (0.5) 4.6 (0.3) 4.5 (0.3) 30 7.7 (0.6) 5.6 (0.3) 4.8 (0.5) 4.7 (0.3) 5.0 (0.5) 4.1 (0.6) 4.7 (0.3) 31 8.2 (0.7) 6.0 (0.6) 5.1 (0.3) 4.9 (0.5) 5.3 (0.4) 4.2 (0.3) 4.9 (0.4) 32 8.5 (0.6) 6.1 (0.6) 5.2 (0.4) 5.1 (0.4) 5.4 (0.4) 4.4 (0.6) 5.0 (0.6) 33 8.6 (0.4) 6.4 (0.5) 5.4 (0.5) 5.3 (0.3) 5.6 (0.5) 4.5 (0.5) 5.2 (0.3) 34 8.9 (0.5) 6.6 (0.6) 5.7 (0.5) 5.5 (0.4) 5.8 (0.5) 4.7 (0.5) 5.4 (0.5) 35 8.9 (0.7) 6.7 (0.6) 5.8 (0.4) 5.6 (0.4) 5.9 (0.6) 4.8 (0.6) 5.4 (0.4) 36 9.1 (0.7) 7.0 (0.7) 6.0 (0.6) 5.6 (0.5) 6.0 (0.6) 4.9 (0.5) 5.5 (0.3) 37 9.3 (0.9) 7.2 (0.4) 6.1 (0.4) 6.0 (0.4) 6.1 (0.4) 5.1 (0.3) 5.6 (0.4) 38 9.5 (0.6) 7.4 (0.6) 6.2 (0.3) 6.0 (0.4) 6.4 (0.3) 5.1 (0.5) 5.8 (0.6) 39 9.5 (0.6) 7.6 (0.8) 6.4 (0.7) 6.1 (0.6) 6.5 (0.6) 5.3 (0.5) 6.0 (0.6) 40 9.9 (0.8) 7.7 (0.4) 6.5 (0.3) 6.2 (0.1) 6.6 (0.4) 5.3 (0.3) 6.0 (0.5) 41 9.7 (0.6) 7.7 (0.4) 6.6 (0.4) 6.3 (0.5) 6.6 (0.4) 5.6 (0.4) 6.3 (0.5) 42 10.0 (0.5) 7.8 (0.7) 6.8 (0.5) 6.7 (0.7) 6.8 (0.7) 5.7 (0.5) 6.5 (0.5)
BIPARIETAL
DIAMETER
FEMUR TIBIA FIBULA HUMERUS RADIUS ULNA
Bone
4.8 (0.4) 4.0 (0.5) 4.5 (0.4)
From Merz E, Kim-Kern MS, Pehl S: Ultrasonic mensuration of fetal limb bones in the second and third trimesters. J Clin Ultrasound 1987;5:175-183.
*Mean values (cm); value of 2 SD in parentheses.
1392 PART IV Obstetric Sonography
A B C
D
E
G H
FIGURE 40-2. Normal femur and spectrum of abnormal appearances. A, Normal femur: measure the longest length,
excluding the proximal and distal epiphysis and the specular reflection of the lateral aspect of the distal femoral epiphysis (arrow). B, Normal femur in the near field, with straight lateral border versus the curved medial border in the far field of the transducer. C, Isolated hypoplastic left femur (arrowhead), with normal tibia (black arrow) and foot (white arrow). D, Osteogenesis imperfecta type I. Isolated femoral fracture with acute angulation (arrow). E, Campomelic dysplasia. Mild shortening and a gently curved ventral femoral bowing (arrow). F, Osteogenesis imperfecta type IIA. Bowed femur with multiple discontinuities representing fractures. G, Hypophosphatasia congenita. Severe micromelia (relatively broad metaphysis, short diaphysis). H, Thanatophoric dysplasia. Curved, “telephone receiver’’ femur. I, Chondrodysplasia punctata. Third-trimester appearance of a stippled epiphysis. (C courtesy Ants Toi, MD; D and E courtesy Shia
Salem, MD; University of Toronto.)
In the lower extremity the lateral bone is the fibula and the medial bone is the tibia. The tibia and fibula end at the same level distally. In the upper extremity, pronation may cause the radius and ulna to cross, so it can be difficult to distinguish the ulna from the radius using lateral and medial positions. The ulna is distin­guished from the radius by its longer proximal extent and its relationship to the fifth digit distally. The radius
and ulna end at the same level distally. Demonstration of this relationship will effectively exclude the majority of radial ray defects.
The clavicles grow in a linear fashion, approximately 1 mm per week, and the gestational age in weeks is approximately the length of the clavicle in millimeters from 14 weeks to term. By 40 weeks’ gestation, the clavicles measure approximately 40 mm.
F
I
19
Chapter 40 The Fetal Musculoskeletal System 1393
A B
FIGURE 40-3. Foot length measurement. From the skin edge overlying the calcaneus to the distal end of the longest toe. A,
Sagittal measurement; note the normal squared appearance of the heel. B, Plantar measurement.
Foot length is measured from the skin edge overlying
the calcaneus to the distal end of the longest toe (the first or second toe) on either the plantar or the sagittal
20-22
view
(Fig. 40-3). The ossified femur length is almost equivalent to the foot length, resulting in a normal femur/foot length ratio of approximately 1.0. This ratio remains relatively constant from the 14th week of gestation onward. If the fetus is constitutionally small or there is symmetrical IUGR, the ratio is generally 0.9 or greater. In most skeletal dysplasias characterized by short limbs, the ratio is generally less than 0.9 because of the relative sparing of the hands and feet. The greater the deviation from the lower limits of the norm, the greater is the severity.
SONOGRAPHIC EVALUATION OF FETUS WITH SKELETAL DYSPLASIA
A prenatal evaluation of a skeletal dysplasia is indicated if there is a positive family history or an abnormal length or appearance of the bones at ultrasound.
ASSESSMENT OF SKELETAL
DYSPLASIAS: KEY FEATURES
Family history Serial measurements Degree of limb shortening Pattern of limb shortening Presence of bowing, fractures, and angulations Spine Thoracic measurements Hands and feet Calvarium and facial features
Positive Family History
A positive family history of a sibling or parents affected by a skeletal dysplasia or consanguineous parents should prompt an intensive ultrasound investigation with a focus on targeted abnormalities and serial measurements. A history of consanguinity is important because many of the skeletal dysplasias have an autosomal recessive mode of inheritance. Heterozygous achondroplasia, the most common nonlethal skeletal dysplasia, has an autosomal dominant pattern of inheritance. Family history may not be helpful because 80% of cases are caused by a new dominant mutation.
Abnormal Bone Length or Appearance
The fetal femur is often the only long bone routinely measured at the second-trimester ultrasound evaluation. An abnormal FL is traditionally defined as below 2 standard deviations (SD) for gestational age.
23,24
Using this cutoff, 2.5% of all fetuses would be classified as having short limbs. This exceeds the expected fre­quency of skeletal dysplasias, and thus additional inves­tigations are needed to identify the fetus with a skeletal dysplasia.
When one or all of the long bones measure less than
2 SD for gestational age, a follow-up ultrasound should
be done in 3 to 4 weeks to evaluate the interval growth. If the interval femur growth is normal, there is a high likelihood that the fetus does not have skeletal dysplasia. However, further deviation from the mean by at least 1 SD should suggest the presence of a skeletal dysplasia or severe IUGR. When FL measures below 4 SD for gestational age, there is a high likelihood of a skeletal dysplasia. Kurtz et al.23 have shown that the number of millimeters below the
2 SD line is a simple screening
1394 PART IV Obstetric Sonography
tool to evaluate femoral shortening with the following guidelines:
• If FL is 1 to 4 mm below the 2 SD point, further
serial measurements are required to determine if a skeletal dysplasia is present.
• If FL is greater than 5 mm below the 2 SD point,
there is a high likelihood of a skeletal dysplasia.
The most common etiology of a so-called short femur is either inaccurate dating or a normal variant in a con­stitutionally small fetus, which may be associated with a parental or family history of less-than-average stature. In about 13% of cases, a remeasurement will bring the FL into a normal range, likely representing a false-positive diagnosis rather than a growth-spurt.
25
Isolated, sym­metrical short femurs identified at the second midtrimes­ter ultrasound evaluation are helpful in identifying a group of fetuses at increased risk for low birth weight, small for gestational age, or severe IUGR.
25-27
Typically, these fetuses will also have small abdominal circumfer­ence measurements.
Occasionally, severe IUGR may present with greatly
shortened long bones.
28
Associated findings of normal or decreased skin fold measurements, oligohydramnios, abnormal placental morphology, and abnormal Doppler waveforms suggest the diagnosis of IUGR,
29
whereas redundant, thickened skin folds and polyhydramnios typically accompany short-limb dysplasias.
Nonlethal skeletal dysplasias such as heterozygous achondroplasia are generally not evident before 20 weeks’ gestation. The findings of short long bones before 20 weeks indicate a more serious and usually fatal skel­etal dysplasia. As a rule, the earlier the detection of limb
shortening, the worse is the prognosis. Virtually all cases diagnosed in first trimester are considered severe skeletal dysplasias, with the greater majority representing lethal conditions. available.
30
First-trimester skeletal biometry tables are
31
Although mild, isolated shortening of the femur indicates increased risk for trisomy 21 by 1.5­fold, other factors are more important for assessing this risk.
32
The pattern of limb shortening should be assessed to determine which long-bone segments are most severely affected
8,33
(Fig. 40-4). Rather than millimeters, we find it useful to standardize measurements to “weeks of size” to determine disproportion. There are four main pat­terns of shortening of the long bones: rhizomelia, short­ening of the proximal segment (femur and humerus); mesomelia, shortening of the middle segment (radius, ulna, tibia, and fibula); acromelia, shortening of the distal segment (hands and feet); and micromelia, shortening of the entire limb (mild, mild/bowed, or severe).
PATTERNS OF LIMB SHORTENING
Rhizomelia: shortening of proximal segment
(femur, humerus).
Mesomelia: shortening of middle segment (radius,
ulna/tibia, fibula).
Acromelia: shortening of distal segment (hands,
feet).
Micromelia: shortening of entire limb (mild, mild/
bowed, severe).
FIGURE 40-4. Patterns of limb shortening. Left to right, Normal, mesomelia, rhizomelia, mild micromelia, mild and curved
micromelia, and severe micromelia. (Drawing courtesy J. Tomash, MD, University of Toronto.)
A B
Chapter 40 The Fetal Musculoskeletal System 1395
FIGURE 40-5. In lethal skeletal dysplasias, assessment of the fetal spine
ossification centers can provide helpful clues to the specific diagnosis. The following cases are all lethal on the basis of pulmonary hypoplasia, as evidenced by short ribs and a small thoracic circumference. A, Short-rib polydactyly syndrome with normal ossification of all three spine ossifica­tion centers (circle). B, Achondrogenesis with demineralization of all three spine ossification centers (circle). C, Hypophosphatasia with demineraliza-
C
tion of the posterior ossification centers but mineralization of the vertebral body (circle).
The shape, contour, and density of the bones should be assessed for the presence of bowing, angulations, frac­tures, or thickening. Bowing is a nonspecific finding, typically caused by underlying osseous fragility. Although more than 40 distinct disorders can be associated with bowed, bent, or angulated femurs, the majority (63%) belong to three disorders: campomelic dysplasia (24.4%), thanatophoric dysplasia (23.9%) and osteo- genesis imperfecta (OI) (18.1%).
34
Patients with OI types I and IV can present with apparent in utero bowing and shortening without frank fractures of the long bones (see Fig. 40-2, D). Anterior bowing of the tibia, femur, and humerus may suggest the diagnosis of campomelic dysplasia; associated findings such as hypoplastic scapu-
lae and cervical kyphosis are typically present. Bone fractures may appear as angulations or interruptions in
the bone contour or as thick, wrinkled contours corre­sponding to repetitive cycles of fracture and callus for­mation (Fig. 40-2, F). Decreased or absent acoustic shadowing is a marker for decreased mineralization of the long bones. When evident, this is helpful, but in its absence the bone mineralization may still be abnormal.
The spine is assessed for segmentation anomalies, kyphoscoliosis, platyspondyly (flattened vertebral bodies), demineralization, myelodysplasia, and caudal regression syndromes. Although platyspondyly is the most common spine abnormality, it is a challenging pre­natal diagnosis.
35
Demineralization of the spine can result in the appearance of ghost vertebrae or nonvisualization of one or all of the three ossification centers (Fig. 40-5). A progressively narrowed lumbar interpedicular distance is associated with achondroplasia; a widened interpedicu­lar distance is associated with myelodysplasia.
The most important prognostic determinant of the lethality of a given skeletal dysplasia is the presence of pulmonary hypoplasia. Ultrasound is 85% to 95% accurate in the diagnosis of a lethal skeletal dysplasia on the basis of pulmonary hypoplasia.
7,8
The thoracic cir- cumference is measured at the level of the four-chamber heart and compared to nomograms (see Table 36-1). A thoracic/abdominal circumference ratio of less than 0.8 is considered abnormal. The thoracic length (from the neck to the diaphragm) is also measured, and the ribs are assessed to determine if they are short. At the level of the
1396 PART IV Obstetric Sonography
A B C
FIGURE 40-6. Triplet B affected with campomelic dysplasia and pulmonary hypoplasia. Coronal ultrasound
images of the thorax in triplet pregnancy at 27 weeks’ gestation. A, Normal triplet A shows normal convex contour of the thorax. Calipers measure the scapula. B, Triplet B shows a bell-shaped thorax. C, Radiograph of triplet B confirms a bell-shaped thorax consistent with pulmonary hypoplasia.
four-chamber cardiac view, the ribs should normally encircle at least 70% to 80% of the thoracic circumfer-
36
The ribs remain in a relatively horizontal plane, as
ence. does the cardiac axis, facilitating this evaluation. In a sagit­tal view, a markedly narrowed anteroposterior (AP) diam­eter of the thorax is associated with pulmonary hypoplasia. In the coronal view, a concave or bell-shaped contour is
1
associated with pulmonary hypoplasia (Fig. 40-6).
The hands and feet are examined for deformities such as clubfoot or clubhand. A hitchhiker thumb, or abducted thumb, is associated with diastrophic dwarf- ism. Fixed postural deformities may suggest the diagno­sis of arthrogryposis multiplex congenita. Polydactyly is associated with short-rib polydactyly syndromes,
Ellis–van Creveld syndrome, asphyxiating thoracic dystrophy and some chromosomal abnormalities.
The fetal cranium is assessed for the presence of macrocranium, frontal bossing, cloverleaf skull deformity, underlying brain abnormalities, and facial abnormalities, such as saddle nose, hypertelorism, and cleft lip and palate. An abnormal cranial contour may
12
indicate craniosynostosis or premature fusion of the sutures. The most reliable sonographic sign of deminer­alization is increased compressibility of the calvarium. This finding is typically present in osteogenesis imper- fecta type II, achondrogenesis, and hypophosphata-
FIGURE 40-7. Normal ribs: 3-D ultrasound.
sia. The falx may appear abnormally bright or echogenic compared to the demineralized calvarium.
The ribs are assessed to ensure an adequate length, thus minimizing the risk of pulmonary hypoplasia, and are examined for abnormal number or appearance.
37
The finding of an abnormal number of fetal ribs is an isolated finding of no clinical importance in the majority of
37
associated with minor anomalies in a smaller
cases, group (29%) and only occasionally associated with severe malformations. Associated syndromes include Poland syndrome, VACTERL association (vertebral abnormali­ties, anal atresia, cardiac abnormalities, tracheoesopha-
geal fistula, renal agenesis and dysplasia, limb defects), cleidocranial dysplasia, campomelic dysplasia, and chromosome abnormalities. Three-dimensional ultra­sound volume images aid in accurately counting the number of ribs (Fig. 40-7).
Ultimately, a detailed examination of each bone may be required to determine the fetal condition. Specific dysmorphic features of bones (e.g., clavicular or scapular hypoplasia; aplasia of fibula, tibia, or radius; platyspon­dyly) can be helpful to further define a specific skeletal dysplasia. A detailed evaluation of the cardiovascular,